A resolution repealing standing orders relating to flowers in the Senate Chamber.
- Last Action
- 1/17/2024
Actions
- 2023-02-16Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2023-02-16Introduced in Senate
CRS Summary
As of 2023-02-16 (00)
Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 or the BENEFIT Act of 2023
This bill requires the Food and Drug Administration (FDA) to consider relevant patient experience data in the risk-benefit assessment framework used in the process for approving new drugs.
After a new drug application has been approved, the FDA's public statement about how it used patient experience data shall include a description of how such data was considered in the risk-benefit assessment framework.
Cosponsors (5)
- Amy Klobuchar (D-MN)
- Susan Collins (R-ME)
- Mike Braun (R-IN)
- Rick Scott (R-FL)
- Bill Hagerty (R-TN)
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.